Hyderabad-based Biological E Limited’s Covid-19 vaccine Corbevax has emerged as the first vaccine to bag approval from the Drug Controller General of India for use as a heterologous booster dose, for those aged 18 years and above, after 6 months of administration of the second dose of either Covaxin or Covishield.
from Times of India https://ift.tt/dNMwzTC
Saturday, 4 June 2022
Subscribe to:
Post Comments (Atom)
Bollywood News And Much More In Gujarati Language. Gujarati Literature. Excellent Coverage. Premium Content. Most Accurate
No comments:
Post a Comment